Ruben G Nava
Overview
Explore the profile of Ruben G Nava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
655
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Terada Y, Li W, Amrute J, Bery A, Liu C, Nunna V, et al.
Cell Rep
. 2025 Mar;
44(3):115380.
PMID: 40042972
Triggering receptor expressed on myeloid cells 1 (TREM-1) has been shown to amplify inflammatory signals, such as Toll-like receptor signaling, after infection and sterile injury. While previous studies have demonstrated...
2.
Gauthier J, Terada Y, Takahashi T, Nava R, Kreisel D, Meyers B, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
2(3):563-566.
PMID: 39790388
Background: Organ procurement organizations coordinate organ donation through 2 distinct models of care: the conventional model, in which donors are managed at hospitals where brain death occurs, and the specialized...
3.
Tohmasi S, Eaton Jr D, Rossetti N, Pickett C, Heiden B, Yan Y, et al.
J Thorac Dis
. 2024 Nov;
16(10):6727-6739.
PMID: 39552891
Background: Currently, there is no consensus on how to comprehensively assess comorbidities in lung cancer patients in the clinical setting. Prescription medications may be a preferred comorbidity assessment tool and...
4.
Bai Y, Yan Y, Chang S, Yang Z, Delhi A, Farahnak K, et al.
J Thorac Cardiovasc Surg
. 2024 Sep;
PMID: 39226995
Background: There is a critical shortage of donor lungs for transplantation. We previously developed a parsimonious, highly discriminatory 9-variable Lung Donor (LUNDON) acceptability score. Here we assessed the utility of...
5.
Rossetti N, Eaton Jr D, Tohmasi S, Heiden B, Schoen M, Yan Y, et al.
Ann Thorac Surg
. 2024 Aug;
118(5):1117-1125.
PMID: 39178931
Background: Lung cancer screening guidelines were introduced in the United States in 2013, with variable implementation. This study evaluated temporal diagnostic trends in non-small cell lung cancer (NSCLC) diagnosis since...
6.
Bai Y, Yokoyama Y, Li W, Terada Y, Kreisel D, Nava R
J Vis Exp
. 2024 Jul;
(209).
PMID: 38981107
This corrects the article 10.3791/66232.
7.
Brandt W, Yang Z, Heiden B, Samson P, Morgensztern D, Waqar S, et al.
J Thorac Dis
. 2024 Jun;
16(5):2894-2905.
PMID: 38883676
Background: Large, node-negative but locally invasive non-small cell lung cancer (NSCLC) is associated with increased perioperative risk but improved survival if a complete resection is obtained. Factors associated with positive...
8.
Bai Y, Terada Y, Mineura K, Yokoyama Y, Nava R, Krupnick A, et al.
J Vis Exp
. 2024 May;
(206).
PMID: 38709031
Complications after lung transplantation are largely related to the host immune system responding to the graft. Such immune responses are regulated by crosstalk between donor and recipient cells. A better...
9.
Bai Y, Yokoyama Y, Li W, Terada Y, Kreisel D, Nava R
J Vis Exp
. 2024 Apr;
(206).
PMID: 38682909
Ischemia reperfusion injury (IRI) during lung transplantation is a major risk factor for post-transplant complications, including primary graft dysfunction, acute and chronic rejection, and mortality. Efforts to study the underpinnings...
10.
Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score
Yang Z, Bai Y, Yan Y, Hachem R, Witt C, Vazquez Guillamet R, et al.
Am J Transplant
. 2024 Mar;
24(7):1279-1288.
PMID: 38531429
Lung transplantation (LTx) continues to have lower rates of long-term graft survival compared with other organs. Additionally, lung utilization rates from brain-dead donors remain substantially lower compared with other solid...